| Lamoille Hha 54 Farr Avenue, Morrisville, VT, 05661 | |
| (802) 888-4651 |
News Archive
Population studies strongly suggest that colon cancer risk is reduced in those who are physically active. Enlarged crypt lesions in the colon are early signs of increasing risk of colon cancer.
Using a drug-discovery technique in which molecules compete against each other for access to the target - the strand of toxic RNA that causes the most common form of muscular dystrophy in adults - a team at the University of Rochester Medical Center has identified several compounds that, in the laboratory, block the unwanted coupling of two molecules that is at the root of the disease.
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
Researchers at The University of Nottingham are studying whether people's genetic makeup could make them more likely to develop osteoarthritis of the knee and hip — the most common medical condition to affect the joints.
Sanford Burnham Prebys professor Peter D. Adams, Ph.D., who directs the Aging, Cancer and Immuno-oncology Program and Salk Institute professor Gerald Shadel, Ph.D., who directs the San Diego Nathan Shock Center of Excellence in the Basic Biology of Aging, have been awarded a grant from the NIH's National Institute on Aging for $13 million, funding a five-year project to explore the connection between aging and liver cancer.
› Verified 3 days ago
| Name | Lamoille Hha |
|---|---|
| Location | 54 Farr Avenue, Morrisville, Vermont |
| Hospice ID | 471503 |
| Category | Part of a Home Health Agency |
| Ownership Type | Other |
| Profit Type | OTHER |
| SSA county code | 070 |
News Archive
Population studies strongly suggest that colon cancer risk is reduced in those who are physically active. Enlarged crypt lesions in the colon are early signs of increasing risk of colon cancer.
Using a drug-discovery technique in which molecules compete against each other for access to the target - the strand of toxic RNA that causes the most common form of muscular dystrophy in adults - a team at the University of Rochester Medical Center has identified several compounds that, in the laboratory, block the unwanted coupling of two molecules that is at the root of the disease.
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
Researchers at The University of Nottingham are studying whether people's genetic makeup could make them more likely to develop osteoarthritis of the knee and hip — the most common medical condition to affect the joints.
Sanford Burnham Prebys professor Peter D. Adams, Ph.D., who directs the Aging, Cancer and Immuno-oncology Program and Salk Institute professor Gerald Shadel, Ph.D., who directs the San Diego Nathan Shock Center of Excellence in the Basic Biology of Aging, have been awarded a grant from the NIH's National Institute on Aging for $13 million, funding a five-year project to explore the connection between aging and liver cancer.
› Verified 3 days ago
| NPI Number | 1932258209 |
| Organization Name | Lamoille Home Health Agency, Inc. |
| Address | 54 Farr Ave Morrisville, Vermont, 05661 |
| Phone Number | (802)888-4651 |
News Archive
Population studies strongly suggest that colon cancer risk is reduced in those who are physically active. Enlarged crypt lesions in the colon are early signs of increasing risk of colon cancer.
Using a drug-discovery technique in which molecules compete against each other for access to the target - the strand of toxic RNA that causes the most common form of muscular dystrophy in adults - a team at the University of Rochester Medical Center has identified several compounds that, in the laboratory, block the unwanted coupling of two molecules that is at the root of the disease.
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
Researchers at The University of Nottingham are studying whether people's genetic makeup could make them more likely to develop osteoarthritis of the knee and hip — the most common medical condition to affect the joints.
Sanford Burnham Prebys professor Peter D. Adams, Ph.D., who directs the Aging, Cancer and Immuno-oncology Program and Salk Institute professor Gerald Shadel, Ph.D., who directs the San Diego Nathan Shock Center of Excellence in the Basic Biology of Aging, have been awarded a grant from the NIH's National Institute on Aging for $13 million, funding a five-year project to explore the connection between aging and liver cancer.
› Verified 3 days ago
| Quality Measure | Provider Score | National Score |
|---|---|---|
| Patients or caregivers who were asked about treatment preferences like hospitalization and resuscitation at the beginning of hospice care | 100.0 | 98.3 |
| Patients or caregivers who were asked about their beliefs and values at the beginning of hospice care | 100.0 | 93.6 |
| Patients who were checked for pain at the beginning of hospice care | 97.2 | 93.9 |
| Patients who got a timely and thorough pain assessment when pain was identified as a problem | 98.0 | 77.7 |
| Patients who were checked for shortness of breath at the beginning of hospice care | 100.0 | 97.3 |
| Patients who got timely treatment for shortness of breath | 97.2 | 94.6 |
| Patients taking opioid pain medication who were offered care for constipation | 100.0 | 93.3 |
News Archive
Population studies strongly suggest that colon cancer risk is reduced in those who are physically active. Enlarged crypt lesions in the colon are early signs of increasing risk of colon cancer.
Using a drug-discovery technique in which molecules compete against each other for access to the target - the strand of toxic RNA that causes the most common form of muscular dystrophy in adults - a team at the University of Rochester Medical Center has identified several compounds that, in the laboratory, block the unwanted coupling of two molecules that is at the root of the disease.
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
Researchers at The University of Nottingham are studying whether people's genetic makeup could make them more likely to develop osteoarthritis of the knee and hip — the most common medical condition to affect the joints.
Sanford Burnham Prebys professor Peter D. Adams, Ph.D., who directs the Aging, Cancer and Immuno-oncology Program and Salk Institute professor Gerald Shadel, Ph.D., who directs the San Diego Nathan Shock Center of Excellence in the Basic Biology of Aging, have been awarded a grant from the NIH's National Institute on Aging for $13 million, funding a five-year project to explore the connection between aging and liver cancer.
› Verified 3 days ago
| Home Health Aides | 4.91 |
| Homemakers | 7.88 |
| Licensed Practical or Vocational Nurses | 0.13 |
| Medical Social Workers | 0.82 |
| Physicians | 0.01 |
| Registered Nurses | 13.64 |
| Other Personnel | 21.1 |
| Total Employees | 48.49 |
|---|
News Archive
Population studies strongly suggest that colon cancer risk is reduced in those who are physically active. Enlarged crypt lesions in the colon are early signs of increasing risk of colon cancer.
Using a drug-discovery technique in which molecules compete against each other for access to the target - the strand of toxic RNA that causes the most common form of muscular dystrophy in adults - a team at the University of Rochester Medical Center has identified several compounds that, in the laboratory, block the unwanted coupling of two molecules that is at the root of the disease.
Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company's lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong
Researchers at The University of Nottingham are studying whether people's genetic makeup could make them more likely to develop osteoarthritis of the knee and hip — the most common medical condition to affect the joints.
Sanford Burnham Prebys professor Peter D. Adams, Ph.D., who directs the Aging, Cancer and Immuno-oncology Program and Salk Institute professor Gerald Shadel, Ph.D., who directs the San Diego Nathan Shock Center of Excellence in the Basic Biology of Aging, have been awarded a grant from the NIH's National Institute on Aging for $13 million, funding a five-year project to explore the connection between aging and liver cancer.
› Verified 3 days ago
| Lamoille Hha Location: 54 Farr Avenue, Morrisville, Vermont, 05661 Phone: (802) 888-4651 |